Share Name Share Symbol Market Type Share ISIN Share Description
Tristel Plc LSE:TSTL London Ordinary Share GB00B07RVT99 ORD 1P
  Price Change % Change Share Price Shares Traded Last Trade
  22.50 5.45% 435.00 30,951 09:19:42
Bid Price Offer Price High Price Low Price Open Price
430.00 440.00 435.00 420.00 420.00
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Health Care Equipment & Services 26.17 4.75 9.14 47.6 197
Last Trade Time Trade Type Trade Size Trade Price Currency
09:21:21 O 1,500 431.50 GBX

Tristel (TSTL) Latest News

More Tristel News
Tristel Takeover Rumours

Tristel (TSTL) Discussions and Chat

Tristel Forums and Chat

Date Time Title Posts
08/4/202021:48The TRISTEL story2,779
14/9/201814:56MRSA cleaner249
15/7/201513:01Tristel PLC: Cleaning up the sector340
03/1/201004:54tristel with charts-
13/2/200607:10TSTL with Charts & News3

Add a New Thread

Tristel (TSTL) Most Recent Trades

Trade Time Trade Price Trade Size Trade Value Trade Type
View all Tristel trades in real-time

Tristel (TSTL) Top Chat Posts

Tristel Daily Update: Tristel Plc is listed in the Health Care Equipment & Services sector of the London Stock Exchange with ticker TSTL. The last closing price for Tristel was 412.50p.
Tristel Plc has a 4 week average price of 280p and a 12 week average price of 280p.
The 1 year high share price is 502p while the 1 year low share price is currently 264p.
There are currently 45,176,846 shares in issue and the average daily traded volume is 144,565 shares. The market capitalisation of Tristel Plc is £196,519,280.10.
makw61: The fall in share price coincided with the announcement that the NHS were stopping routine operations so i guess it reflects concern over reduced demand for instrument decontamination etc. Seems a bit overdone - with high PE stocks most of the value is well into the future, not current year earnings, and the long term prospects have likely increased post Covid 19.
metis20: Piedro - "At Tristel the exertion seems minimal, repeating the old formula and letting the momentum carry them forward." What evidence do you have for this?! Did you attend a recent Investor Presentation? The impression I obtained at the late afternoon session was of a decidedly hard working and innovative duo leading the company. Https:// Share holder approval was of course required. Vesting conditions - that was when the share price was £2.75 · One-third will vest upon the achievement of a share price of £3.50; · One-third will vest upon the achievement of a share price of £4.25; · One-third will vest upon the achievement of a share price of £5.00. Between 4 August 2015 and 1 November 2017, the Company's share price has increased from 96 pence to 275 pence, and the Company's market capitalisation has increased from £40 million to £118 million. The Board considers that the 2015 Scheme has successfully met its objectives.
salchow: "Profits up, share price down..why?" US approval takes longer and costs more than anticipated. Already an expensive share.
trapperjez: Profits up, share price down..why?
metis20: From FY (ending June 2018) final results - "The corollary to achieving these targets is that we are likely to be highly cash generative given the operational cash requirements of the business. If the Board considers that there are no earnings enhancing opportunities to invest excess cash, a special dividend will be paid to shareholders. The Board's pursuit of these financial objectives is grounded in the belief that consistent and sustainable increases in earnings and dividends will, over time, result in share price growth." Https:// From H1 (ending Dec 2017)report - "During the first half a final dividend of 2.63 pence per share was paid, totalling £1.1m. At the period end cash was £4.9m compared to £3.9m on 31 December 2016. We will pay an interim dividend of 1.6 pence per share on 12 April 2018 to shareholders on the register on 23 March 2018, with an ex-dividend date of 22 March 2018. Our policy is to cover the dividend with earnings by at least two times and pay 40% as an interim and 60% as a final." Https://
gopher: Attended the open day in the summer when share price was close to 300p and directors took the opportunity to slot a few At 220p much more reasonably priced for a good quality small cap with opportunity to grow the business. That growth needs to come from abroad as the NHS is a difficult market for all UK suppliers aa there is moral pressure to keep prices low.
sportii: Only a good news from the American front can change the momentum of the share price. Sooner the better!
piedro: To quote the Walbrock report ... "Look to the cash flow statement, and you see share-based payment rose to £665k from £121k. Management rewarded themselves with large bonuses, despite missing earnings forecast. The cancellation of its special dividends took the yield down to 1.6% from approx. 2.5%. To be fair to management, the company share price rose from 30 pence to £2.59, an increase of 760% in the last five years. Surely, management deserves their bonuses for delivering long-term gains to shareholders." - long term investors will remember the pain back in 2010 when the management took the share price from 60p down to 20p - they had to get in outside help to pick the company up again - now again ... "We are working to appoint new Non-Executive Directors to bring fresh ideas and new experiences to our Board" {Annual Report} - the present chairman was only supposed to be 'Interim' - going by past experience, I am thinking that circumstances are obliging him to let go and there may yet be unwelcome revelations to come - I would not be surprised if it was not this same management that is stifling the young talent within the company AIMO, BWDIK GLA and ride the storm.
melton john: "they do not provide the incentive to improve the share price" One-third will vest upon the achievement of a share price of GBP3.50; One-third will vest upon the achievement of a share price of GBP4.25; One-third will vest upon the achievement of a share price of GBP5.00. Why on earth would you be happy if they vested "at or near the current share price" Have I missed something?
piedro: New Share Option Scheme The 2018 Scheme The 2018 Scheme will be put forward for approval by shareholders at the Company's Annual General Meeting. If the 2018 Scheme is approved 990,000 share options will be granted on 1 January 2018 as follows: · Paul Swinney 500,000 options; · Elizabeth Dixon 400,000 options; · Paul Barnes 45,000 options; · David Orr 45,000 options. The options will be exercisable at 1 penny per share and will vest in three equal tranches as follows: · One-third will vest upon the achievement of a share price of £3.50; · One-third will vest upon the achievement of a share price of £4.25; · One-third will vest upon the achievement of a share price of £5.00. To vest, the average share price of Tristel plc must be above the hurdle rate for a minimum three-month period In the event of a change of control of the Company all options will vest. Any vested but unexercised options will expire on 30 June 2021. As an additional condition, the options will only be exercisable if the holder commits to hold the resulting ordinary shares until 30 June 2021 or, if sooner, until a change of control of the Company occurs. - I would prefer @ £4.50, £6.00 and £7.50 - and do not enjoy the talk of change of control - a change of CEO and Chairman, yes AIMHO
Tristel share price data is direct from the London Stock Exchange
ADVFN Advertorial
Your Recent History
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20200409 08:37:35